Chronic Itch
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2018: 12:00 AM
Ends On:
6/30/2019: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Brian S. Kim, MD, MTR, FAAD
Assistant Professor, Medicine (Dermatology), Anesthesiology, and Pathology and Immunology
Co-Director, Center for the Study of Itch
Disclosures
Consultant for Regeneron Pharmaceuticals, Inc. and Incyte Corporation
Research Grants from Celgene and LEO Pharmaceuticals
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Clinical Allergy for the Practicing Physician, August 11-12, 2017, which was supported in part by Shire HGT, Inc., CSL Behring, and Lincoln Diagnostics, Inc.
Tiffany Dy, MD
Assistant Professor, Medicine
Allergy and Immunology
Disclosures: No financial relationships to disclose.
Andrew L. Kau, MD, PhD
Instructor, Medicine
Division of Allergy/Immunology
Disclosures
Ownership Investment in Gilead Sciences, National Institutes of Health, and AAAAI Trust
Jennifer Monroy, MD
Assistant Professor, Medicine
Division of Allergy/Immunology
Disclosures: No financial relationships to disclose.
Sandra Odenwald, RN
Clinical Nurse Coordinator
Division of Allergy/Immunology
Disclosures: No financial relationships to disclose.
Faculty
Brian S. Kim, MD, MTR, FAAD
Assistant Professor, Medicine (Dermatology), Anesthesiology, and Pathology and Immunology
Co-Director, Center for the Study of Itch
Disclosures
Consultant for Regeneron Pharmaceuticals, Inc. and Incyte Corporation
Research Grants from Celgene and LEO Pharmaceuticals
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Clinical Allergy for the Practicing Physician, August 11-12, 2017, which was supported in part by Shire HGT, Inc., CSL Behring, and Lincoln Diagnostics, Inc.
Planning Committee
Tiffany Dy, MD
Assistant Professor, Medicine
Allergy and Immunology
Disclosures: No financial relationships to disclose.
Andrew L. Kau, MD, PhD
Instructor, Medicine
Division of Allergy/Immunology
Disclosures
Ownership Investment in Gilead Sciences, National Institutes of Health, and AAAAI Trust
Jennifer Monroy, MD
Assistant Professor, Medicine
Division of Allergy/Immunology
Disclosures: No financial relationships to disclose.
Sandra Odenwald, RN
Clinical Nurse Coordinator
Division of Allergy/Immunology
Disclosures: No financial relationships to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Outline different causes of chronic itch.
- Present new data in the treatment of chronic idiopathic pruritus (CIP).
- Highlight new and emerging treatments for atopic dermatitis and its associated itch.
Additional Information:
Target Audience: This course is designed for allergists, immunologists, pulmonologists, primary care and family practice physicians, otolaryngologists, pediatricians, internists, dermatologists, nurse practitioners, physician assistants, nurses and all allied health professionals who care for patients with allergic and immunologic illnesses.
Date
Publication Date: July 1, 2018
Expiration Date: June 30, 2019
Target Audience: This course is designed for allergists, immunologists, pulmonologists, primary care and family practice physicians, otolaryngologists, pediatricians, internists, dermatologists, nurse practitioners, physician assistants, nurses and all allied health professionals who care for patients with allergic and immunologic illnesses.
Date
Publication Date: July 1, 2018
Expiration Date: June 30, 2019
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
This activity is awarded up to .5 ANCC contact hour.
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
This activity is awarded up to .5 ANCC contact hour.
References:
- Cevikbas et al. J Allergy Clin Immunol 2014 Feb;133(2):448-60
- Dillon et al. Nat Immunol 2004 Jul;5(7):752-60
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
